Stocks at New 52-Week Highs — Financial View · Biological Products, (No Diagnostic Substances)
6 stocks match the Stocks at New 52-Week Highs screen. Stocks that have just made a fresh 52-week high — breakout stocks with strong momentum. Financial columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–6 of 6
| BIIB | Biogen | $33.1B | — | 4.7% | 7.4% | 5.5% | 3.06 | 0.34 | 75.5% | 28.6% | 13.8% | 224.49 | +0.78% | 32K |
| EXEL | Exelixis, Inc. | $14.7B | — | 34.5% | 46.7% | 46.7% | 3.46 | 0.00 | 96.5% | 39.9% | 35.3% | 59.13 | +1.00% | 116K |
| HALO | Halozyme Therapeutics, Inc. | $12.6B | — | 16.0% | — | 19.9% | 2.71 | 13.50 | 82.4% | 35.9% | 24.9% | 110.73 | +1.01% | 90K |
| REPL | Replimune Group, Inc. | $1.4B | — | — | — | — | 5.23 | 0.80 | — | — | — | 15.28 | -4.32% | 50K |
| ATTO | Attovia Therapeutics, Inc. | $1.2B | — | — | — | — | 9.39 | -0.11 | — | — | — | 25.33 | +3.56% | 23K |
| ARGX | Argenx Se | — | — | — | — | — | — | — | — | — | — | 1053.32 | -0.21% | 8K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.